Video
29 Jul 2024
New Cell Culture Facility in Vienna
PNG 317 kB
We are is raising the bar with the LSCC (Large Scale Cell Culture), the new biopharmaceutical multi-product facility, in Vienna. It is one of the most modern buildings of its kind with a high degree of automation and flexibility.
Content provided by our supplier
Boehringer Ingelheim Biopharmaceuticals GmbH
-
Country/Region:Germany
-
On CPHI since:2023
-
Employees:5000+
Company types
Other Content from Boehringer Ingelheim Biopharmaceuticals GmbH (4)
-
News A Day in the Life of a Senior Director at Boehringer Ingelheim
In our Day in the Life of series we love getting to know the people at the heart of pharma. In this latest interview we speak to Sanobar Syed, Senior Director at Boehringer Ingelheim, about her career and what she feels is most important for the future of the industry.
-
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA).
-
Whitepaper Advancements in microbial manufacturing of biopharmaceuticals
Advancements in Microbial Manufacturing of Biopharmaceuticals: A Historical Perspective and Future Outlook.
